Amia Capital LLP Esperion Therapeutics, Inc. Transaction History

Amia Capital LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$24.2 - $35.76 $495,228 - $731,792	-20,464 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $13,688 - $23,139	-439 Reduced 2.1%	20,464 $761,000
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $348,133 - $594,631	-11,589 Reduced 35.67%	20,903 $1.07 Million
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $221,468 - $595,962	-8,071 Reduced 19.9%	32,492 $1.02 Million
Q4 2019 Feb 13, 2020	BUY	$35.4 - $59.82 $1.44 Million - $2.43 Million	40,563 New	40,563 $2.42 Million

199

136M

2.72M

1.3M

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $144M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.